Miralex Sp. z o.o.   Report issue

For profit
Founded: Poznan Poland (1990)
Status: No NME R&D (1990)

Organization Overview

First Clinical Trial
2018
NCT03462160
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Miralex Sp. z o.o.

Active Ingredients

Drugs in Other Trials (2)

lactobacillus plantarum (1 trial)

lactobacillus rhamnosus (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2